Search

everythinglearnresearchcommunity

for

Search:↓

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Finasteride shows promise for female hair loss, but more research needed.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Finasteride effectively treats male hair loss, improving growth and density.

Menopause affects hair and skin; more research needed for treatment.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Intermediate hair follicles are a better model for studying hair growth and testing hair loss treatments.

Finasteride improves surrounding scalp hair and increases hair density after hair transplant.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Finasteride may help some women with hair loss, but better options exist.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.